Weiss Multi-Strategy Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,000	Closed	-$2.36M	–	815
2014 Q1	$2.36M	Buy	+30,000	New	+$2.5M	0.05%	322
2013 Q3	–	Sell	-15,000	Closed	-$869K	–	946
2013 Q2	$869K	Buy	+15,000	New	+$867K	0.03%	404

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IBB Position: Q2 2016 in Review

Weiss Multi-Strategy Advisers sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 6,000 shares — an estimated $522K sold.

Weiss Multi-Strategy Advisers first reported a position in IBB in Q1 2016 and held it in 1 quarter. The position peaked at $522K in Q1 2016. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Weiss Multi-Strategy Advisers reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 6,000 iShares Biotechnology ETF shares in Q2 2016, an estimated $522K.
Weiss Multi-Strategy Advisers first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 1 quarter.
Weiss Multi-Strategy Advisers's iShares Biotechnology ETF position peaked at $522K in Q1 2016.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.